Clinical Trial News and Research

RSS

No adverse side-effects have been observed in clinical trial of SARS vaccine

Sinovac Biotech has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with either SARS vaccine or placebo.

11 Aug 2004

American Indians and Alaska Natives are 2.3 times as likely to have diabetes as non-Hispanic whites of similar age

About 40 percent of adults ages 40 to 74 - or 41 million people - have pre-diabetes, a condition that raises a person's risk of developing type 2 diabetes, heart disease, and stroke.

11 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

Effects of oxidative stress on atherosclerosis

Heart disease and stroke are the first and third leading causes of death among men and women in the United States and account for 40 percent of all mortalities, according to the Centers for Disease Control and Prevention.

9 Aug 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

New screening test for oesophageal (food pipe) cancer

A new screening test for oesophageal (food pipe) cancer could dramatically improve survival from the disease, according to research published in the British Journal of Cancer this week.

5 Aug 2004

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT).

3 Aug 2004

New gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients

Experts on the Gene Therapy Advisory Committee have given the go ahead for a large clinical trial of a new treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure.

3 Aug 2004

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

The four-year clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease, a degenerative disorder of the central nervous system.

3 Aug 2004

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

Recommendation against the use of chemotherapy sensitivity and resistance assays

A new technology assessment from the American Society of Clinical Oncology states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.

3 Aug 2004

One-third of U.S. adults use some form of alternative medicine

More than one-third of U.S. adults use some form of alternative medicine such as herbal supplements and other therapies, showed in a nationwide survey by NIH's National Center for Complementary and Alternative Medicine published in May 2004.

2 Aug 2004

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Early intervention with a novel kind of "smart gene therapy" might effectively prevent the organ damage commonly suffered by heart attack victims, suggests a new animal study by researchers at Brigham and Women's Hospital in Boston and Duke University Medical Center.

2 Aug 2004

Continuous glucose sensor technology has the potential to revolutionize diabetes management

Findings published in the August 2004 issue of Diabetes Care indicate that a new analytical tool -- the Continuous Glucose Error-Grid Analysis (CG-EGA) -- which was created to evaluate the clinical accuracy of continuous glucose monitoring in people with diabetes, shows that continuous monitoring can provide highly accurate test results.

2 Aug 2004

Tool that enables women with breast cancer to choose their own course of treatment

McMaster University cancer researcher, Tim Whelan, a radiation oncologist with the Juravinski Cancer Centre, has developed a tool that enables women with breast cancer to choose their own course of treatment.

29 Jul 2004

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu

PRB Pharmaceuticals and Lee's Pharmaceuticals have announced the discovery that PRB'S patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu (H3N2) infections in vitro.

29 Jul 2004

Study requires patients for new type of silicone-gel breast implants

Researchers at UT Southwestern Medical Center at Dallas are looking for women to participate in the second phase of a study of a new cohesive silicone-gel breast implant.

27 Jul 2004

Donepezil may have short-term benefit for mild cognitive impairment

People with mild cognitive impairment (MCI) taking the drug donepezil were at reduced risk of progressing to Alzheimer's disease (AD) for the first 18 months of a 3-year study when compared with their counterparts on placebo

26 Jul 2004

$1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease

The Muscular Dystrophy Association has announced it has awarded $1.6 million to Asklepios, a biotechnology company closely allied with the University of North Carolina at Chapel Hill, to develop gene therapy strategies for Duchenne muscular dystrophy (DMD), a fatal, childhood-onset disease.

23 Jul 2004

Clinical Trial News and Research

No adverse side-effects have been observed in clinical trial of SARS vaccine

American Indians and Alaska Natives are 2.3 times as likely to have diabetes as non-Hispanic whites of similar age

Clinical trial of lipase inhibitor for the treatment of obesity

Effects of oxidative stress on atherosclerosis

Approval of Cymbalta for treatment of major depressive disorder

New screening test for oesophageal (food pipe) cancer

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

New gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Recommendation against the use of chemotherapy sensitivity and resistance assays

One-third of U.S. adults use some form of alternative medicine

Smart gene therapy might effectively prevent the organ damage commonly suffered by heart attack victims

Continuous glucose sensor technology has the potential to revolutionize diabetes management

Tool that enables women with breast cancer to choose their own course of treatment

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu

Study requires patients for new type of silicone-gel breast implants

Donepezil may have short-term benefit for mild cognitive impairment

$1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News